-

Northwell Labs to Have Coronavirus Testing Capabilities Within a Week

LAKE SUCCESS, N.Y.--(BUSINESS WIRE)--Northwell Health Labs announced today it expects to begin testing for the coronavirus within a week, now that the US Food & Drug Administration (FDA) has given the green light for outside labs to conduct the COVID-19 tests once appropriately validated.

At a news conference today with US Senator Charles Schumer at the 101,000-square foot Core Lab within Northwell’s Center for Advanced Medicine in Lake Success, Dwayne Breining, MD, executive director of laboratory services at Northwell, said manual testing for coronavirus could begin this week, with 75-100 tests processed daily. Once the lab automates the process, it will have the capability to process hundreds and eventually thousands of tests daily, he said.

“Once the process is fully automated, we will have the ability to conduct tests within three-to-four hours of receiving samples at the lab, and report the results immediately,” said Dr. Breining.

Prior to this week, all nasopharyngeal swab samples from patients who met the criteria for testing established by the US Centers for Disease Control & Prevention (CDC) had to be sent to the CDC’s lab in Atlanta for testing. The turnaround time for results was multiple days. To date, Northwell has referred only four samples from suspected cases to the CDC for testing.

“If the virus continues to spread (there is currently only one confirmed case in New York and about 86 nationwide), the ability to have local lab-testing capability is vitally important,” Dr. Breining said.

Over the the next month, he said, the lab is working with test manufacturers to make this testing available within Northwell’s hospitals throughout New York City, Long Island and Westchester County, further expanding the health system’s ability to respond to an epidemic. Those facilities are already doing rapid molecular testing for the seasonal flu using similar technology. “With local labs, you can test quicker and get the results quicker,” he added.

The expanded ability to test patients for COVID-19 will greatly enhance Northwell’s ability to manage patients with potential infection. However, given the limited testing capacity and the CDC’s current recommendations, patients with milder symptoms who do not require hospitalization will not be tested. Such testing is currently reserved for patients who have had contact with someone infected with the virus, or those who are very sick and will require hospitalization.

Over the past six weeks, Northwell has already invested more than $5 million on coronavirus preparation, including more than $2 million for lab testing and supplies.

Constructed at a cost of $59.6 million and opened in 2019, the Core Lab features North America’s largest Roche Diagnostics automated testing line of its kind – and one of the biggest in the world. It currently processes more than 20 million tests annually.

Throughout all of its hospitals and approximately 800 outpatient locations, Northwell continues to maintain a vigilant approach to protecting patients, staff and local communities from the virus. The health system’s clinical protocols are designed to quickly identify potential infectious patients as they enter our facilities, isolate them appropriately, prevent transmission of infections, and protect front-line caregivers from potential exposure.

“Northwell is well-prepared to manage the challenges posed by the coronavirus, as evidenced by our response to previous infectious disease outbreaks, including our Anthrax response in 2001, SARS in 2003, swine flu in 2009 and Ebola in 2014,” said Northwell Health President & CEO Michael Dowling. “It’s important for people to remain calm and take practical steps such as routine handwashing to protect against not only the coronavirus -- but the flu, which has already affected 26 million Americans this season and killed more than 16,000.”

About Northwell Health
Northwell Health is New York State’s largest health care provider and private employer, with 23 hospitals, about 750 outpatient facilities and more than 13,600 affiliated physicians. We care for over two million people annually in the New York metro area and beyond, thanks to philanthropic support from our communities. Our 70,000 employees – 16,000-plus nurses and 4,000 employed doctors, including members of Northwell Health Physician Partners – are working to change health care for the better. We’re making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Graduate Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Twitter, Instagram and LinkedIn.

Contacts

Terry Lynam / Barbara Osborn
516-316-2389 / 516-312-6754
tlynam@northwell.edu / bosborn@northwell.edu

Northwell Health Labs


Release Versions

Contacts

Terry Lynam / Barbara Osborn
516-316-2389 / 516-312-6754
tlynam@northwell.edu / bosborn@northwell.edu

More News From Northwell Health Labs

Feinstein Institutes’ Research Pinpoints Core Cause of Vascular Cognitive Impairment, Unlocking New Therapeutic Avenues for Cognitive Decline

MANHASSET, N.Y.--(BUSINESS WIRE)--Scientists at Northwell Health’s Feinstein Institutes for Medical Research have uncovered a critical mechanism driving vascular cognitive impairment (VCI), the world’s second most common form of dementia after Alzheimer’s disease. Their findings, published this month in Alzheimer’s & Dementia, pinpoint the dysregulation of vasoactive neuropeptides, or key regulators of blood-vessel tone, as the root cause of microvascular dysfunction in VCI. This discovery...

Feinstein Institutes Awarded $4M Grant to Develop AI-Powered Speech Based ‘Vital Signs’ to Improve Psychosis Diagnosis and Treatment

MANHASSET, N.Y.--(BUSINESS WIRE)--Northwell Health’s Feinstein Institutes for Medical Research received $4 million from the National Institute of Mental Health (NIMH) to improve how severe mental health conditions are assessed and treated. By using an AI-powered advanced speech and language analysis, the research aims to develop personalized metrics to gauge the severity of psychosis. This research has the potential to transform the way patients with mental illness are diagnosed and treated, le...

Feinstein Institutes secures $3.37M grant to strengthen first responder mental health and resilience

MANHASSET, N.Y.--(BUSINESS WIRE)--Recent reports show that one in seven first responders have probable post-traumatic stress disorder (PTSD) in response to routine duties with prevalence increasing after responding to a crisis. To improve our understanding and the well-being of these essential heroes, researchers at Northwell Health’s Feinstein Institutes for Medical Research, Stony Brook University and Texas A&M University received a $3.37-million grant from the National Institute of Menta...
Back to Newsroom